MELANIE MORRIS: Open Payments
NPI 1871593020 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 16 payments from 12 companies in 2025. Trend: 2023 $769 · 2024 $695 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| Endologix LLC | 2 | $128 |
| ABBVIE INC. | 1 | $115 |
| Actelion Pharmaceuticals US, Inc. | 2 | $97 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Amgen Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| HEARTFLOW, INC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: ENDOCROSS Device, VRAYLAR, UPTRAVI, LEQVIO, LOKELMA, OPSUMIT, ONPATTRO, REPATHA.
Industry payments across TX — which companies pay providers there.
